JDRF Blog

JDRF Research Strategy: Cures and Improving Lives

They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

Read More About JDRF Research Strategy: Cures and Improving Lives

JDRF Urges Congress to Fund Diabetes Research

On June 4, JDRF’s President & CEO Aaron J. Kowalski, Ph.D., testified before the U.S. House of Representatives Committee on Energy &...

Read More About JDRF Urges Congress to Fund Diabetes Research

Insulin Discovered Nearly 100 Years Ago: How Far We’ve Come and the Road Ahead

Incredible strides have been made since the discovery of insulin almost 100 years ago. Insulin formulations have improved dramatically, blood-sugar levels can...

Read More About Insulin Discovered Nearly 100 Years Ago: How Far We’ve Come and the Road Ahead

Advancing the Cure with Type 1 Diabetes Clinical Trials

 JDRF funds type 1 diabetes (T1D) clinical trials that are critical to bringing new devices and treatments to people with this disease....

Read More About Advancing the Cure with Type 1 Diabetes Clinical Trials

Recent Articles

  • JDRF Research Strategy: Cures and Improving Lives

    May 31, 2019

    They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

    Read more

  • The 20th Anniversary of the Edmonton Protocol

    March 11, 2019

    This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999, the Edmonton...

    Read more

  • At ADA, JDRF-Funded Research Takes Center Stage

    June 17, 2019

    JDRF was there when the top type 1 diabetes (T1D) experts from all over the world convened this month at the American...

    Read more

  • ADA Scientific Sessions Recap—Day #5: Marlon Pragnell, Ph.D.

    June 12, 2019

    The ADA’s Scientific Sessions is completed! Here, with the post-day recap, is Marlon Pragnell, Ph.D., head of the complications program at JDRF,...

    Read more

  • Two T1D Technology Leaders Partnering to Drive Innovation and Choice

    June 11, 2019

    Two leading innovators in the T1D space have announced a collaborative partnership aimed at enabling those with T1D to select favorite devices,...

    Read more

  • ADA Scientific Sessions Recap—Day #4: Simi Ahmed, Ph.D.

    June 11, 2019

    The American Diabetes Association’s Scientific Sessions is almost coming to a close! Here is Simi Ahmed, Ph.D., head of the immunotherapy program...

    Read more

  • ADA Scientific Sessions Recap—Day #3.5: Jessica Dunne, Ph.D.

    June 10, 2019

    There was some really exciting prevention research in day #3, and also screening for type 1 diabetes risk. Here is Jessica Dunne,...

    Read more

  • A New AP System by Tandem Shows Key Time-in-Range Benefits

    June 10, 2019

    A new artificial pancreas system that both doses and takes away insulin is showing critical benefits in helping those with type 1...

    Read more

  • ADA Scientific Sessions Recap—Day #3: Dan Finan, Ph.D.

    June 10, 2019

    There was some really amazing results out here in San Francisco! Here is Dan Finan, Ph.D., head of the JDRF’s artificial pancreas...

    Read more

  • First Human Study to Significantly Delay—by Two Years!—Type 1 Diabetes Onset

    June 9, 2019

    This is big. No, wait, this is ENORMOUSLY HUGE. Published today in the New England Journal of Medicine, an immunotherapy demonstrated a...

    Read more